SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-029209
Filing Date
2022-08-12
Accepted
2022-08-12 06:54:11
Documents
66
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ubx-10q_20220630.htm   iXBRL 10-Q 3076831
2 EX-31.1 ubx-ex311_7.htm EX-31.1 21401
3 EX-31.2 ubx-ex312_6.htm EX-31.2 21237
4 EX-32.1 ubx-ex321_8.htm EX-32.1 15451
  Complete submission text file 0001564590-22-029209.txt   10012987

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ubx-20220630.xsd EX-101.SCH 67808
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ubx-20220630_cal.xml EX-101.CAL 53493
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ubx-20220630_def.xml EX-101.DEF 231006
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ubx-20220630_lab.xml EX-101.LAB 488248
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ubx-20220630_pre.xml EX-101.PRE 370328
60 EXTRACTED XBRL INSTANCE DOCUMENT ubx-10q_20220630_htm.xml XML 1780840
Mailing Address 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 416-1192
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

IRS No.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38470 | Film No.: 221157764
SIC: 2834 Pharmaceutical Preparations